Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Boehringer Ingelheim

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Boehringer Ingelheim's 2013 sales performance.

Boehringer Ingelheim GmbH

Lilly drops Hanmi-partnered arthritis drug

Lilly drops Hanmi-partnered arthritis drug

The Korean firm has negotiated a series of alliances in the last three years with pharma multinationals - includingand Boehringer Ingelheim - although the latter ended in disappointment in 2016. ... Boehringer handed back rights to EGFR inhibitor

Another Alzheimer's bust as Merck stops verubecestat study

Another Alzheimer's bust as Merck stops verubecestat study Since the start of the year, Boehringer Ingelheim has stopped development of its PDE9a inhibitor BI 4093906, Takeda and Zinfandel abandoned efforts to repurpose diabetes drug pioglitazone for the disease, and

Boehringer abandons PDE-targeted Alzheimer’s drug

Boehringer abandons PDE-targeted Alzheimer’s drug Boehringer abandons PDE-targeted Alzheimer’ s drug. But will keep testing the candidate in schizophrenia. ... Boehringer Ingelheim has said it will halt development of its Alzheimer’s disease drug BI 409306 after it failed to hit the mark in

Roche’s lung drug Esbriet reserved for worse cases, says NICE

Roche’s lung drug Esbriet reserved for worse cases, says NICE Boehringer Ingelheim’s Ofev subject to same conditions. Roche’s idiopathic pulmonary fibrosis drug Esbriet will be available routinely on the NHS in England and Wales, but only for patients with ... Those are the same conditions applied to Boehringer

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the...

Latest intelligence

Erik
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...
Deal Watch January 2018
...

Infographics